BEGIN:VCALENDAR VERSION:2.0 PRODID:-//ChamberMaster//Event Calendar 2.0//EN METHOD:PUBLISH X-PUBLISHED-TTL:P1H REFRESH-INTERVAL:P1H CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU DTSTART:20070101T000000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:Eastern Daylight Time END:DAYLIGHT BEGIN:STANDARD RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU DTSTART:20070101T000000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:Eastern Standard Time END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20261208T140000 DTEND;TZID=America/New_York:20261208T150000 X-MICROSOFT-CDO-ALLDAYEVENT:FALSE SUMMARY:Advancing Care in Intra-Abdominal Candidiasis: Exploring the Potential of Rezafungin DESCRIPTION:This webinar explores the challenges of managing intra-abdominal candidiasis (IAC) and the potential role of rezafungin. Designed for surgeons and other healthcare professionals\, the session reviews current treatment recommendations\, emerging clinical evidence\, and considerations for transitioning patients from hospital to outpatient care. Participants will gain insights to help them:Recognize the clinical burden of IAC and key risk factors in critically ill patients.Understand guideline recommendations for antifungal therapy\, including the role of echinocandins and the importance of source control.Evaluate the evidence for rezafungin\, including findings from STRIVE and ReSTORE and emerging data specific to intra-abdominal infections.Explore how once-weekly therapy may support transitions of care.\n \nSpeakersLuis Ostrosky-Zeichner\nMD\, FACP\, FIDSA\, FSHEA\, FECMM\, CMQ\nUTHealth Houston\nID PhysicianDr. Ostrosky-Zeichner received his medical degree from Universidad Nacional Autonoma de Mexico\, completed his internal medicine residency at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran\, and his infectious diseases fellowship at the University of Texas Health Science Center at Houston/MD Anderson Cancer Center combined program. He is currently a Professor of Medicine and Epidemiology and the Memorial Hermann Endowed Chair at the University of Texas Health Science Center at Houston\, where he is appointed as the Vice Chairman of Medicine for Healthcare Quality and the Division Chief at the Division of Infectious Diseases. He also serves as the Chief Epidemiology Officer for the Memorial Hermann Healthcare System. He has consulted for the FDA and the CDC. He has published over 250 peer-reviewed articles and actively pursues translational and clinical research in medical mycology\, transplant infectious diseases\, healthcare epidemiology\, and antimicrobial stewardship.\nJared M. Huston\nMD\, FACS\, FSIS\, SMNAI\nNorthwell Health X-ALT-DESC;FMTTYPE=text/html:

This webinar explores the challenges of managing intra-abdominal candidiasis (IAC) and the potential role of rezafungin. Designed for surgeons and other healthcare professionals\, the session reviews current treatment recommendations\, emerging clinical evidence\, and considerations for transitioning patients from hospital to outpatient care. \;

 \;

Participants will gain insights to help them:


 \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;  \;

Speakers

Luis Ostrosky-Zeichner
MD\, FACP\, FIDSA\, FSHEA\, FECMM\, CMQ
UTHealth Houston
ID Physician

Dr. Ostrosky-Zeichner received his medical degree from Universidad Nacional Autonoma de Mexico\, completed his internal medicine residency at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran\, and his infectious diseases fellowship at the University of Texas Health Science Center at Houston/MD Anderson Cancer Center combined program. \;

He is currently a Professor of Medicine and Epidemiology and the Memorial Hermann Endowed Chair at the University of Texas Health Science Center at Houston\, where he is appointed as the Vice Chairman of Medicine for Healthcare Quality and the Division Chief at the Division of Infectious Diseases. \;

He also serves as the Chief Epidemiology Officer for the Memorial Hermann Healthcare System. He has consulted for the FDA and the CDC. He has published over 250 peer-reviewed articles and actively pursues translational and clinical research in medical mycology\, transplant infectious diseases\, healthcare epidemiology\, and antimicrobial stewardship.


Jared M. Huston
MD\, FACS\, FSIS\, SMNAI
Northwell Health



LOCATION: UID:e.4103.1685550 SEQUENCE:3 DTSTAMP:20261115T052743Z URL:https://portal.sisna.org/events/Details/advancing-care-in-intra-abdominal-candidiasis-exploring-the-potential-of-rezafungin-1987705?sourceTypeId=Hub END:VEVENT END:VCALENDAR